Liver international : official journal of the International Association for the Study of the LiverHumansDiabetes MellitusType 2Sodium-Glucose Transporter 2 InhibitorsFemale
SGLT-2 Inhibitors Are Associated With Lower Mortality and Decompensation in Patients With MASH Cirrhosis and Type 2 Diabetes.
Do Han Kim, Donghyun Ko, Vincent L Chen, Jose A Porres, Carlos Elizondo Alatorre, Luis M Nieto, Pedro Palacios Argueta, Paul T Kröner, Frank J Lukens, Donghee Kim, Raffi Karagozian, Meena B Bansal, Karn Wijarnpreecha
Published: 202610.1111/liv.70490
Abstract
INTRODUCTION: Metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH) represent a spectrum of liver conditions that can gradually progress to cirrhosis. Sodium-glucose co-transporter-2 (SGLT-2) inhibitors have show…
Preview only. Read the full abstract at the source